Longitudinal analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte responses: A predominant gag-specific response is associated with nonprogressive infection

Journal of Infectious Diseases

Volumn 178, Issue 4, 1998, Pages 1008-1018

  Pontesilli, Oscar ^c   Klein, Michèl R ^b   Kerkhof Garde, Susana R ^c   Pakker, Nadine G ^c   De Wolf, Frank ^c   Schuitemaker, Hanneke ^c   Miedema, Frank ^a  

^a CLB   (Netherlands)

^b MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; NEF PROTEIN; RNA DIRECTED DNA POLYMERASE; VIRUS ENVELOPE PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CELLULAR IMMUNITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; SURVIVAL RATE; VIRUS LOAD;

EID: 0031664158     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515659     Document Type: Article

References (19)

1. McMichael AJ, Walker BD. Cytotoxic T lymphocyte epitopes: implications for HIV-1 vaccines. AIDS 1994;8(suppl 1):S155-73.
2. Koup RA, Safrit JT, Cao Y, et al. Temporal associations of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994;68:4650-5.
3. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994;68:6103-10.
4. Borrow P, Lewicki H, Wei X, et al. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nature Med 1997;3:205-11.
5. Musey L, Hughes J, Schaker T, Shea T, Corey L, McElrath MJ. Cytotoxic T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N Engl J Med 1997;337:1267-74.
6. Walker BD, Chakrabarti S, Moss B, et al. HIV-1-specific cytotoxic T lymphocytes in seropositive individuals. Nature 1987;328:345-8.
7. Lamhamedi-Cherradi S, Culmann-Penciolelli B, Guy B, et al. Qualitative and quantitative analysis of human cytotoxic T-lymphocyte responses to HIV-1 proteins. AIDS 1992;6:1249-58.
8. Klein MR, Van Baalen CA, Holwerda AM, et al. Kinetics of Gag-specific CTL responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J Exp Med 1995;181:1365-72.
9. Zinkernagel RM, Hengartner H. T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS. Immunol Today 1994;15:262-8.
10. Zinkernagel RM. Are HIV-specific CTL responses salutary or pathogenic? Curr Opin Immunol 1995;7:462-70.
11. Autran B, Mayaud CM, Raphael M, et al. Evidence for a cytotoxic T-lymphocyte alveolitis in human immunodeficiency virus-infected patients. AIDS 1988;2:179-83.
12. Jassoy C, Johnson RP, Navia BA, Worth J, Walker BD. Detection of a vigorous HIV-1-specific cytotoxic T lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex. J Immunol 1992;149:3113-9.
13. Rinaldo CR, Huang XL, Fan Z, et al. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J Virol 1995;69:5838-42.
14. Carmichael A, Jin X, Sissons P, Borysiewicz L. Quantitative analysis of the human immunodeficiency virus type 1 (HlV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J Exp Med 1993;177:249-56.
15. Hoffenbach A, Langlade-Demoyen P, Dadaglio G, et al. Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. J Immunol 1989;142:452-62.
16. Van Griensven GJP, Tielman RAP, Goudsmit J, et al. Risk factors and prevalence of HIV antibodies in homosexual men in the Netherlands. Am J Epidemiol 1987;125:1048-57.
17. Anonymous. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. MMWR Morb Mortal Wkly Rep 1986;35:334-9.
18. Anonymous. Revision of the CDC surveillance case definition of acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep 1987; 36(suppl 1):1S-15S.
19. Anonymous. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992;41(RR-17):1-19.